BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8489340)

  • 1. The use of a commercially available enzyme immunoassay for the detection of Clostridium difficile toxin A.
    Gilligan PH; Walden TP; Kelly WF; Wait KJ; Kraft JA; Willis DH
    Arch Pathol Lab Med; 1993 May; 117(5):507-10. PubMed ID: 8489340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing toxigenic Clostridium difficile: new confidence bounds show culturing increases sensitivity of the toxin A/B enzyme immunoassay and refute gold standards.
    Mattner F; Winterfeld I; Mattner L
    Scand J Infect Dis; 2012 Aug; 44(8):578-85. PubMed ID: 22404319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.
    Reyes RC; John MA; Ayotte DL; Covacich A; Milburn S; Hussain Z
    Diagn Microbiol Infect Dis; 2007 Sep; 59(1):33-7. PubMed ID: 17662566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Clostridium difficile toxins in stools. Comparison between a new enzyme immunoassay for toxin A and other routine tests.
    Depitre C; Avesani V; Delmée M; Corthier G
    Gastroenterol Clin Biol; 1993; 17(4):283-6. PubMed ID: 8339887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of methods for detection of toxins in specimens of feces submitted for diagnosis of Clostridium difficile-associated diarrhea.
    O'Connor D; Hynes P; Cormican M; Collins E; Corbett-Feeney G; Cassidy M
    J Clin Microbiol; 2001 Aug; 39(8):2846-9. PubMed ID: 11474001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of different methods for detection of Clostridium difficile toxins in Poland.
    Martirosian G; Pituch H; Obuch-Woszczatyński P; Rouyan G; Meisel-Mikołajczyk F
    Acta Microbiol Pol; 1999; 48(4):349-53. PubMed ID: 10756719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
    Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
    Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of five commercial tests for the rapid diagnosis of Clostridium difficile-associated disease.
    Miendje Deyi VY; Vandenberg O; Mascart G; Gning S; Retore P; Douat N; Dediste A
    Clin Lab; 2008; 54(1-2):9-13. PubMed ID: 18510038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infections in HIV-positive patients.
    Wongwanich S; Ramsiri S; Kusum M; Warachit P
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):537-9. PubMed ID: 11289016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the latex agglutination test for detection of Clostridium difficile.
    Kelly WF; Wait KJ; Gilligan PH
    Arch Pathol Lab Med; 1992 May; 116(5):517-20. PubMed ID: 1580756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile testing algorithms: what is practical and feasible?
    Schmidt ML; Gilligan PH
    Anaerobe; 2009 Dec; 15(6):270-3. PubMed ID: 19853666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of enzyme immunoassays to detect Clostridium difficile toxin from anaerobic stool culture.
    She RC; Durrant RJ; Petti CA
    Am J Clin Pathol; 2009 Jan; 131(1):81-4. PubMed ID: 19095569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the immunoenzyme test (Elisa) in detecting Clostiridium difficile toxin A in fecal samples].
    Barbut F; Caburet F; Petit JC
    Ann Biol Clin (Paris); 1992; 50(1):31-6. PubMed ID: 1443788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
    Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
    Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Clostridium difficile-associated disease: examination of multiple algorithms using toxin EIA, glutamate dehydrogenase EIA and loop-mediated isothermal amplification.
    Bamber AI; Fitzsimmons K; Cunniffe JG; Beasor CC; Mackintosh CA; Hobbs G
    Br J Biomed Sci; 2012; 69(3):112-8. PubMed ID: 23057158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of antibiotic-associated diarrhea with a latex agglutination test and cell culture cytotoxicity assay for Clostridium difficile.
    Biddle WL; Harms JL; Greenberger NJ; Miner PB
    Am J Gastroenterol; 1989 Apr; 84(4):379-82. PubMed ID: 2929558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.